During the past decade, Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 25 clinical trials were completed, i.e. on average, 92.6% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia" are "Breast Cancer" (10 trials), "Neoplasms" (3 trials), "Solid Tumors" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia" in a lesser frequency.

Most popular intervention types in "Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia" are "Drug" (49 trials), "Radiation" (4 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (8 trials), "Carboplatin" (8 trials), "Atezolizumab" (7 trials), "Pertuzumab" (7 trials) and "Placebo" (7 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia" are 42 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia, 13 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".